- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The Feinberg School of Medicine at Northwestern University announces a research faculty position to begin in Fall 2023 in community-engaged research. Community-engaged research centers around collaboration with community stakeholders to co-design, conduct, and disseminate research that benefits health and equity. Community engagement is a major area of study and practice for translational
Register to attend Northwestern University's webinar regarding Data Standardization on Wednesday, May 4, 2022 at 3:00 pm ET. You will hear from Pearl Go, MA, Keith Herzog, MPPA, PMP, Richard T. D'Aquila, MD, Daniel Schneider, MS, and Kristi Holmes, PhD on the features of Northwestern University's joint venture to standardize medication data in an effort to recruit patients for a significant
The Feinberg School of Medicine at Northwestern University announces a research faculty position to begin in Fall 2022, in community-engaged research. Community-engaged research centers collaboration with community stakeholders to co-design, conduct, and disseminate research that benefits health and equity. Community engagement is a major area of study and practice for translational scientific
The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
Provides tools, resources, and approaches for faculty as they develop and/or refine their mentoring skills.
The EQuaTR conference offers professionals in clinical and translational research the opportunity to gain additional knowledge on current trends and issues in clinical research for application in their professional setting. The focus is broad with different themes highlighted year to year.
Vasculitis refers to a group of rare diseases that involve inflammation of blood vessels, which disrupts blood flow and often causes damage to the body’s organs. The cause of most forms of vasculitis remains unknown, and treatments involve the use of strong medications that can have serious side effects. The Vasculitis Clinical Research Consortium (VCRC) is an international, multicenter clinical
Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal
The Department of Preventive Medicine together with the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, seeks to hire an outstanding scientist with extensive experience in conducting cancer molecular epidemiology research for a tenure-track faculty position at the rank of Assistant Professor. Candidates should have demonstrable expertise and
Distrust and evident racism, discrimination, and bias in research and healthcare contribute to underrepresented people and communities of color in research and deepening of racial inequities in health. The Alliance for Research in Chicagoland Communities (www.ARCConline.net) at Northwestern University is working to further our understanding of racism in research and community engagement and
A project to better understand virus-host interaction through the creation of a COVID-19 BioBank and another exploring the effect of COVID-19 on individuals with serious pneumonia have received rapid-response funding from the Northwestern University Clinical and Translational Sciences (NUCATS) Institute and Feinberg School of Medicine Office for Research. The successful grant applications were
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19. The drug being tested is remdesivir, a novel anti-viral drug developed to treat Ebola and which has subsequently been found, in animal models, to have antiviral activity against coronaviruses including MERS and now SARS-Cov-2, the virus that causes COVID-19 disease. The randomized
Nicholas Soulakis, PhD, assistant professor of Preventive Medicine in the Divisions of Health and Biomedical Informatics and Epidemiology, is taking a leave of absence from the medical school to work as an epidemiologist in the Illinois Department of Public Health’s (IDPH) Office of Policy, Planning and Statistics. Soulakis, who specializes in epidemiological surveillance, will help the IDPH
Not many executive bios begin with a crowning achievement in the eighth grade. “Graduating as class president from Horace Mann Elementary School was a big deal. My mom was a teacher there and it helped fulfil early dreams she had for me as I matriculated to St. Ignatius College Prep,” says Melvin Thompson, executive director of the Endeleo Institute, a nonprofit focused on creating a culture of
With an emphasis on educational issues and a goal of sharing resources, best practices and facilitating collaboration, members of the Midwest Consortium (MC) partner to strengthen clinical research education programs, mentoring, and career development opportunities for scholars. The Midwest Consortium for education and research collaboration began in 2006 with three Roadmap K12 institutions
The Strategic Pharma-Academic Research Consortium (SPARC), an organization to spark innovative collaborations in discovery and 'pre-competitive', disease target discovery stage between academic research institutions who are members of the NIH CTSA network and the biopharmaceutical industry. The consortium was established by 4 Midwestern CTSA Hubs as founding partners in 2014, along with two large
This Un-Meeting will explore lifespan and life course research tools and strategies to advance understanding of how the life course may influence outcomes of research participants and how this may be considered in observational and interventional study design. Monday, March 2, 2020 Chicago, Illinois A reception on Sunday, March 1 will precede the Un-Meeting. View event website Un-Meeting on